Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bloomston, M.
Right arrow Articles by Rosemurgy, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloomston, M.
Right arrow Articles by Rosemurgy, A. S.

Annals of Surgical Oncology, Vol 6, Issue 2 195-199, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

One hundred consecutive advanced breast biopsy instrumentation procedures: complications, costs, and outcome

M. Bloomston, P. D'Angelo, D. Galliano, J. Butler Jr, R. Dean and A. S. Rosemurgy
University of South Florida College of Medicine, Tampa, USA.

BACKGROUND: Needle localization and excision have been the preferred techniques for treating nonpalpable mammographic abnormalities. Recently, a less invasive approach, using the Advanced Breast Biopsy Instrumentation (ABBI) system, was introduced. This study was undertaken to determine the feasibility, utility, and cost of this new alternative approach. METHODS: Between April 1996 and May 1997, 100 consecutive women underwent excisional breast biopsies using the ABBI system. Demographic information, mammographic findings, pathological findings, hospital/professional fees, complications, and subsequent interventions were documented. RESULTS: Excisional biopsies using the ABBI system were successful for 99 women (average age, 62 years; range, 34-87 years). Of the 99 lesions removed with the ABBI system, 27 were microcalcifications, 60 were suspicious solid nodules, and 12 were nodules with microcalcifications. The ABBI system was used in an outpatient surgical setting, with only one patient requiring sedation (because of anxiety). Cancer was seen in the biopsy specimens for 18 patients, seven of whom (35%) exhibited no residual tumor at the time of definitive treatment. Postoperative hematomas occurred in two patients; one hematoma required surgical drainage. One missed cancer was detected in follow-up mammograms 6 months after biopsy. The total average procedural cost was $3406.44 +/- 486.63. CONCLUSIONS: Excisional breast biopsy using the ABBI system is an effective diagnostic method. It has a low complication rate, and its cost is comparable to that of classical needle localization.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
V. Doridot, M. Meunier, C. E. Khoury, C. Nos, A. Vincent-Salomon, B. Sigal-Zafrani, and K. B. Clough
Stereotactic Radioguided Surgery by SiteSelect for Subclinical Mammographic Lesions
Ann. Surg. Oncol., February 1, 2005; 12(2): 181 - 188.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. E. March, B. F. Coughlin, R. B. Barham, R. A. Goulart, S. V. Klein, M. E. Bur, J. L. Frank, and G. Makari-Judson
Breast Masses: Removal of All US Evidence during Biopsy by Using a Handheld Vacuum-assisted Device--Initial Experience
Radiology, May 1, 2003; 227(2): 549 - 555.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.